These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 2444169)
1. [Our experience with a hexane extract of Serenoa repens in the treatment of benign prostatic hypertrophy]. Ollé Carreras J Arch Esp Urol; 1987 Jun; 40(5):310-3. PubMed ID: 2444169 [No Abstract] [Full Text] [Related]
2. Serenoa repens (Permixon). A review of its pharmacology and therapeutic efficacy in benign prostatic hyperplasia. Plosker GL; Brogden RN Drugs Aging; 1996 Nov; 9(5):379-95. PubMed ID: 8922564 [TBL] [Abstract][Full Text] [Related]
3. [Serenoa repens--the saw palmetto or dwarf palm]. Swoboda H; Kopp B Wien Med Wochenschr; 1999; 149(8-10):235. PubMed ID: 10483689 [No Abstract] [Full Text] [Related]
4. Saw palmetto extract: newest (and oldest) treatment alternative for men with symptomatic benign prostatic hyperplasia. Marks LS; Tyler VE Urology; 1999 Mar; 53(3):457-61. PubMed ID: 10096366 [No Abstract] [Full Text] [Related]
5. Serenoa repens and benign prostatic hyperplasia: no more effective than placebo. Prescrire Int; 2010 Aug; 19(108):181-2. PubMed ID: 20941857 [TBL] [Abstract][Full Text] [Related]
6. [Saw palmetto fruit extract for treatment of benign prostatic hyperplasia. Results of a placebo-controlled double-blind study]. Bauer HW; Casarosa C; Cosci M; Fratta M; Blessmann G MMW Fortschr Med; 1999 Jun; 141(25):62. PubMed ID: 10897913 [No Abstract] [Full Text] [Related]
7. [Extract of Serenoa repens in the treatment of benign prostatic hyperplasia and lower urinary tract symptoms]. Amdii RE; Al' Shukri AS Urologiia; 2018 May; (2):114-120. PubMed ID: 29901305 [TBL] [Abstract][Full Text] [Related]
8. [Safety of continuous (more than 1 year) intake of Serenoa repens extract by patients with prostatic adenoma]. Vinarov AZ; Aliaev IuG; Lokshin KL Urologiia; 2009; (1):84, 86-7. PubMed ID: 19432240 [No Abstract] [Full Text] [Related]
9. Is there a scientific basis for the therapeutic effects of serenoa repens in benign prostatic hyperplasia? Mechanisms of action. Buck AC J Urol; 2004 Nov; 172(5 Pt 1):1792-9. PubMed ID: 15540722 [TBL] [Abstract][Full Text] [Related]
10. Proven and unproven therapy for benign prostatic hyperplasia. DiPaola RS; Morton RA N Engl J Med; 2006 Feb; 354(6):632-4. PubMed ID: 16467551 [No Abstract] [Full Text] [Related]
11. [Permixon in the treatment of benign prostatic hyperplasia]. Gorilovskiĭ LM Ter Arkh; 1995; 67(8):62-4. PubMed ID: 7482341 [No Abstract] [Full Text] [Related]
12. [Is there a rational therapy for symptomatic treatment of benign prostatic hyperplasia with phytogenic drugs? Illustrated with the example of the prostate agent from Serenoa repens (Sabal fructus)]. Schilcher H Wien Med Wochenschr; 1999; 149(8-10):236-40. PubMed ID: 10483690 [TBL] [Abstract][Full Text] [Related]
15. [Non surgical treatment of benign prostatic hypertrophy]. Martini E; Vaggi L; Rucci A; Di Clemente L J Urol (Paris); 1993; 99(6):278-82. PubMed ID: 7516366 [No Abstract] [Full Text] [Related]
16. Serenoa repens treatment modifies bax/bcl-2 index expression and caspase-3 activity in prostatic tissue from patients with benign prostatic hyperplasia. Vela-Navarrete R; Escribano-Burgos M; Farré AL; García-Cardoso J; Manzarbeitia F; Carrasco C J Urol; 2005 Feb; 173(2):507-10. PubMed ID: 15643230 [TBL] [Abstract][Full Text] [Related]
17. [Five-year experience in treating patients with prostatic hyperplasia patients with permixone (Serenoa repens "Pierre Fabre Medicament)]. Aliaev IuG; Vinarov AZ; Lokshin KL; Spivak LG Urologiia; 2002; (1):23-5. PubMed ID: 11877967 [TBL] [Abstract][Full Text] [Related]
18. What is saw palmetto used for, and does it interact with any medications? Gerber G Health News; 2000 Jun; 6(6):10. PubMed ID: 10917733 [No Abstract] [Full Text] [Related]
19. The role of a lipido-sterolic extract of Serenoa repens in the management of lower urinary tract symptoms associated with benign prostatic hyperplasia. Gerber GS; Fitzpatrick JM BJU Int; 2004 Aug; 94(3):338-44. PubMed ID: 15291864 [TBL] [Abstract][Full Text] [Related]
20. The value of permixon in benign prostatic hypertrophy. Reece Smith H; Memon A; Smart CJ; Dewbury K Br J Urol; 1986 Feb; 58(1):36-40. PubMed ID: 2418902 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]